在结核病抗菌药物敏感性试验期间，需要指导以减轻分析误差的后果。 - Suppr | 超能文献

相似文献

1

Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB.在结核病抗菌药物敏感性试验期间，需要指导以减轻分析误差的后果。

Int J Tuberc Lung Dis. 2021 Oct 1;25(10):791-794. doi: 10.5588/ijtld.21.0428.

2

Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.使用配备TB eXiST的MGIT 960系统测定结核分枝杆菌中贝达喹啉和地拉曼的最低抑菌浓度分布及流行病学截断值。

Antimicrob Agents Chemother. 2015 Jul;59(7):4352-5. doi: 10.1128/AAC.00614-15. Epub 2015 May 4.

3

Resistance to anti-tuberculosis medications in the Horn of Africa.非洲之角的抗结核药物耐药性。

Int J Tuberc Lung Dis. 2011 Mar;15(3):414-6.

4

Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium tuberculosis.

J Med Microbiol. 2017 Jul;66(7):1023-1026. doi: 10.1099/jmm.0.000534.

5

Mycobacterium tuberculosis High-Throughput Screening.结核分枝杆菌高通量筛选

Methods Mol Biol. 2016;1439:181-95. doi: 10.1007/978-1-4939-3673-1_12.

6

Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.结核分枝杆菌药敏试验：BACTEC TB - 460法、流式细胞术检测法与比例法的比较

Clin Microbiol Infect. 2005 May;11(5):372-8. doi: 10.1111/j.1469-0691.2005.01127.x.

7

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.七种抗结核分枝杆菌二线口服药物的野生型分布。

Int J Tuberc Lung Dis. 2011 Apr;15(4):502-9. doi: 10.5588/ijtld.10.0238.

8

Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.结核分枝杆菌对吡嗪酰胺的药敏试验

J Med Microbiol. 2002 Jan;51(1):11-12. doi: 10.1099/0022-1317-51-1-11.

9

Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.吡嗪酰胺在中性pH值和低温条件下对结核分枝杆菌培养物具有活性。

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4956-60. doi: 10.1128/AAC.00654-16. Print 2016 Aug.

10

Synthesis and bioactivity of antitubercular peptides and peptidomimetics: an update.抗结核肽及肽模拟物的合成与生物活性：最新进展

Org Biomol Chem. 2016 Jan 28;14(4):1177-87. doi: 10.1039/c5ob02298c. Epub 2015 Dec 8.

引用本文的文献

1

The c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in .c-54t补偿性突变并不总是结核分枝杆菌中异烟肼耐药性的有效替代指标。（注：原文中“in.”后面缺少具体内容，根据语境补充了“结核分枝杆菌”使句子完整）

Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0026525. doi: 10.1128/aac.00265-25. Epub 2025 Apr 22.

2

A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for complex.需要一种复合参考标准来进行复杂利奈唑胺抗菌药敏试验。

Eur Respir J. 2024 Jul 11;64(1). doi: 10.1183/13993003.00391-2024. Print 2024 Jul.

3

Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant isolates in Wenzhou, China.